Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age

Stopped The study was interrupted due to COVID-19 pandemic and terminated due to new changes to the recommendations for flu vaccines

Conditions

• Influenza

Interventions

• BIOLOGICAL: Quadrivalent influenza vaccine, high-dose
• BIOLOGICAL: Quadrivalent influenza vaccine, standard dose

Sponsor

Sanofi Pasteur, a Sanofi Company